Stock Price

The stock market is on an absolute run. KERX hasn't done a damn thing!!!!!

It's been too long- this time all Senior Leadership needs to go!

Major companies like JNJ and SNY could buy KERX with a small stock swap - their stocks have run so much that they wouldn't even notice changes on their valuations.

KERX needs creative financing to sell this dog!

 

Mgmt and BoD are all about maintaining their bloated comp plans for as long as conceivably possible. Eventually, they will sell their zero cost options and RSUs and still make bank. It's beyond me how no one has been canned yet.

 

The fact that anything is sold displays that the sales force is strong. A stock swap with Shire and they lead the sales force makes sense.

I would've really thought Genzyme (SNY) with all of the people at Keryx with Genzyme ties made sense. I guess Keryx senior leaders are gong to milk this cow dry.

 

Greg and Investor Relations are practicing for next week's quarterly cc: "erm, pleased, uh, encouraged, um, pleased, yeah, encouraged."

 

Remember European approval way back in September, 2015? LOL

 

Remember the stock analyst who incredulously yelled at the management team during one of the quarterly con calls? Unfiltered reality check. Bring that guy back!

 

Company secures formulary status at another large Medicare Part D sponsor -- still a hot piece of garbage! Same worthless rehashes on Thursday's earnings call! We got nothing!

 

22 million shorts can't be wrong. Owned.

 

Since Keryx has not been bought by a bigger company - and it has EU approval along with an American sales force - it makes me wonder how awful senior leadership is?

They issued so many shares that a hostile take over for the little cash flows are not worth it.

An example of a perfect buyer would be Eli Lilly- ample cash and recently had a drug rejected by the FDA. Lilly needs to broaden its portfolio- Keryx has a good drug and a solid sales force. Imagine what could happen with Lilly's ability to get drugs on formulary!

 

stock price: great job, greg!

 

quite possibly the stupidest suggestion Ive seen. Lilly's ability to get drugs on formulary? Um Auryxia is on every major plan in the country

 

So you say- but it's tiered terribly.

 

Goose Egg Greg.

 

“We are very pleased with the recent growth in Auryxia’s prescriptions,” said Scott Holmes.

IR threw a curveball.

 

And the stock touches $6.27. Keryx is not the next Amgen.

 

about to go red for the day. "pleased".

 

This company sucks!

 

When is the offering? GM will throw the wet blanket on this one, for sure.

 

They're back...

 

Never went away.